Open Angle Glaucoma (OAG)
Conditions
Keywords
Glaucoma, DSLT, Interocular Pressure
Brief summary
DSLT demonstrates a ≥ 20% reduction of IOP from pre-treatment baseline in POAG patients naïve of previous glaucoma treatment at 12 months.
Detailed description
DSLT enables newly diagnosed patients to remain well controlled and off medications
Interventions
DEVICEDSLT enables newly diagnosed patients to remain well controlled and off medications
DSLT enables newly diagnosed patients to remain well controlled and off medications
Sponsors
Alcon, a Novartis Company
Barnet Dulaney Perkins Eye Centers
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
30 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Primary open angle glaucoma * Patients age 30 or greater with an IOP of 18-26 mmHg * Mild to moderate POAG patients (mild or moderate according to the AAO PPP Guidelines) * DSLT procedure
Exclusion criteria
* History of prior glaucoma treatment - this includes past medication use (in either eye), previous lasers or incisional surgery * Angle closure patients * Ocular Hypertension * Baseline VF MD of worse than -12dB * Uncontrolled systemic microvascular disease (eg. HTN, DM) * Subjects with peri-limbal findings (e.g. melanosis, tumors, extensive pterygium, significant senile arcus and pterygium)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Success of IOP Reduction Through DSLT Utilization | 12 months | Proportion of patients (%) with DSLT success as defined as IOP lowering of \>20% and no additional medications or procedures at 12 months. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Other Improvements to Disease State through DSLT Treatment | 12 months | • Change in mean deviation.. (dB) |
Countries
United States
Contacts
Primary ContactDerek J Arnson, Master of Education
Backup ContactChristine Funke, Medical Doctor
Outcome results
None listed